Thrombosis Is Reduced by Inhibition of COX-1, but Unaffected by Inhibition of COX-2, in an Acute Model of Platelet Activation in the Mouse

• Paul C. Armstrong,

  Affiliation The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

  ⨯
• Nicholas S. Kirkby,

  Affiliations The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, Cardiothoracic and Stem Cell Pharmacology, National Heart and Lung Institute, Imperial College, London, United Kingdom

  ⨯
• Zetty N. Zain,

  Affiliation The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

  ⨯
• Michael Emerson,

  Affiliation Platelet Biology Group, National Heart and Lung Institute, Imperial College, London, United Kingdom

  ⨯
• Jane A. Mitchell,

  Affiliation Cardiothoracic and Stem Cell Pharmacology, National Heart and Lung Institute, Imperial College, London, United Kingdom

  ⨯
• Timothy D. Warner

  * E-mail: t.d.warner@qmul.ac.uk

  Affiliation The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

  ⨯